Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-277778
Filing Date
2021-09-21
Accepted
2021-09-21 07:12:26
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d213658ds3.htm S-3 137078
2 EX-4.3 d213658dex43.htm EX-4.3 86929
3 EX-5.1 d213658dex51.htm EX-5.1 10349
4 EX-23.1 d213658dex231.htm EX-23.1 1701
5 GRAPHIC g21365844.jpg GRAPHIC 2003
6 GRAPHIC g213658g71d30.jpg GRAPHIC 39983
  Complete submission text file 0001193125-21-277778.txt   289125
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-259680 | Film No.: 211264820
SIC: 2834 Pharmaceutical Preparations